We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$3.85B
1-Year Est. Return
32.11%
This Fund
S&P 500
This Quarter
Est. Return
+1.72%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$780M
AUM Growth
+$181M
(+30%)
Cap. Flow
+$169M
Cap. Flow
% of AUM
21.69%
Top 10 Holdings %
Top 10 Hldgs %
29%
Holding
5,646
New
1,097
Increased
1,409
Reduced
2,025
Closed
1,047
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$111M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$22.4M |
| 3 |
iShares Russell 2000 Growth ETF
IWO
|
+$11.4M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$8.75M |
| 5 |
Invesco Pharmaceuticals ETF
PJP
|
+$8.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$40.7M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$8.86M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$8.19M |
| 4 |
FAZ
Direxion Daily Financial Bear 3x ETF
FAZ
|
+$6.04M |
| 5 |
Vanguard Morningstar Small-Cap Growth ETF
VBK
|
+$5.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.89% |
| 2 | Industrials | 5.11% |
| 3 | Technology | 4.56% |
| 4 | Energy | 4.21% |
| 5 | Healthcare | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Fate Therapeutics
FATE
$326M
| $6K | ﹤0.01% |
600
-9,841
| -94% | -$76K |
|
|
FFIC
3077
DELISTED
Flushing Financial
FFIC
| $6K | ﹤0.01% |
+270
| New | +$5.53K |
|
3078
Gentex
GNTX
$5.07B
| $6K | ﹤0.01% |
378
-1,150
| -75% | -$18.3K |
|
|
GOOD
3079
Gladstone Commercial Corp
GOOD
$627M
| $6K | ﹤0.01% |
+362
| New | +$6.45K |
|
3080
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.2B
| $6K | ﹤0.01% |
420
-2,500
| -86% | -$34.6K |
|
3081
Hudbay
HBM
$12.3B
| $6K | ﹤0.01% |
780
-296
| -28% | -$2.37K |
|
3082
iShares Select U.S. REIT ETF
ICF
$2.11B
| $6K | ﹤0.01% |
142
-25,926
| -99% | -$1.03M |
|
3083
IRIDEX
IRIX
$14.5M
| $6K | ﹤0.01% |
686
-2,314
| -77% | -$21.2K |
|
3084
Landmark Bancorp
LARK
$195M
| $6K | ﹤0.01% |
578
-1,347
| -70% | -$14.6K |
|
3085
Lear
LEA
$8.18B
| $6K | ﹤0.01% |
74
-444
| -86% | -$35.4K |
|
3086
Lee Enterprises
LEE
$182M
| $6K | ﹤0.01% |
150
-148
| -50% | -$6.61K |
|
3087
Live Ventures
LIVE
$29.6M
| $6K | ﹤0.01% |
+150
| New | +$5.77K |
|
3088
LivePerson
LPSN
$32.3M
| $6K | ﹤0.01% |
33
-5
| -13% | -$1K |
|
3089
Macerich
MAC
$6.92B
| $6K | ﹤0.01% |
+92
| New | +$5.47K |
|
|
MHN
3090
DELISTED
BlackRock MuniHoldings New Yrok Quality Fund
MHN
| $6K | ﹤0.01% |
+425
| New | +$5.55K |
|
3091
Moog Inc Class B
MOG.B
$13B
| $6K | ﹤0.01% |
95
-105
| -53% | -$6.69K |
|
3092
Mannatech
MTEX
$9.24M
| $6K | ﹤0.01% |
348
-2,450
| -88% | -$41.1K |
|
3093
BlackRock MuniYield New York Quality Fund
MYN
$377M
| $6K | ﹤0.01% |
500
-500
| -50% | -$6.29K |
|
3094
Vitamin Cottage Natural Grocers
NGVC
$654M
| $6K | ﹤0.01% |
128
-4
| -3% | -$163 |
|
3095
New Mountain Finance
NMFC
$732M
| $6K | ﹤0.01% |
426
+20
| +5% | +$297 |
|
3096
Nortech Systems
NSYS
$43.1M
| $6K | ﹤0.01% |
1,245
-1,739
| -58% | -$9.27K |
|
3097
Nuveen Municipal Value Fund
NUV
$1.91B
| $6K | ﹤0.01% |
594
+410
| +223% | +$3.86K |
|
3098
Nuveen Select Tax-Free Income Portfolio
NXP
$900M
| $6K | ﹤0.01% |
447
+247
| +124% | +$3.31K |
|
3099
Olin
OLN
$2.12B
| $6K | ﹤0.01% |
205
-3,649
| -95% | -$98.3K |
|
3100
PetMed Express
PETS
$42.3M
| $6K | ﹤0.01% |
456
+402
| +744% | +$5.57K |
|
Similar funds
HFCIX
DWM
TFM
AC
IP
TCIM
FLSM
AFI
Tower Research Capital (TRC)'s Q1 2014 Portfolio in Review
As of Q1 2014, Tower Research Capital (TRC) held 5,646 positions worth $780M, up 30% from $599M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Tower Research Capital (TRC) deployed $169M of net new capital in Q1 2014, opening 1,097 new positions and adding to 1,409 existing holdings. Its largest new stake was iShares US Real Estate ETF: 131,900 shares worth $8.93M.
By sector, the portfolio is most concentrated in Financials at 7.9% of assets, down from 8% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $40.7M trimmed.
- Tower Research Capital (TRC)'s largest Q1 2014 buy was iShares US Real Estate ETF: 131,900 shares worth $8.93M.
- Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q1 2014, an estimated $111M increase.
- Tower Research Capital (TRC)'s biggest Q1 2014 reduction was iShares Russell 2000 ETF, cutting an estimated $40.7M.
- Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones Industrial Average ETF Trust in Q1 2014, selling an estimated $8.86M.
- Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $780M portfolio in Q1 2014.
- Tower Research Capital (TRC) opened 1,097 new positions and closed 1,047 in Q1 2014.
- Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $780M.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2014, filed 2 May 2014.